Menu icon

Oncorus

Oncorus
Oncorus

Oncorus, a preclinical-stage biopharmaceutical company focused on the development of systemically administered self-amplifying RNA for cancer treatment, engaged Hilco Streambank to run an out-of-court sale process with respect to its intellectual property. The assets included over 35 issued patents and 100 applications across various jurisdictions, along with supporting research and development materials.

Hilco Streambank ran a sale process over the course of just four weeks, resulting in eight qualified bids for various groupings of assets and ultimately closing three transactions in August 2023.

Let’s connect and work together

If your business or a business in your portfolio is facing a current challenge, our team can provide a qualified perspective and experience-based guidance toward an optimized resolution.
Contact us